Exploratory analysis of a prognosis predictive formula for metastatic colorectal cancer treated with chemotherapy.

被引：0
|
作者：
Tanaka, Mamoru
Kusaba, Hitoshi
Mukaide, Satomi
Kishimoto, Junji
Kumagai, Hozumi
Makiyama, Akitaka
Shirakawa, Tsuyoshi
Oda, Hisanobu
Komoda, Masato
Mitsugi, Kenji
Akashi, Koichi
Baba, Eishi
机构：
[1] Kyushu Univ Hosp, Dept Hematol & Oncol, Fukuoka 812, Japan
[2] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka 812, Japan
[3] Kyushu Univ Hosp, Dept Res & Dev Next Generat Med, Fac Med Sci, Fukuoka 812, Japan
[4] Japan Community Hlth Care Org Kyushu Hosp, Dept Hematol Oncol, Fukuoka, Japan
[5] Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan
[6] Kyushu Natl Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan
[7] Natl Hosp Org Kyushu Med Ctr, Dept Med Oncol, Fukuoka, Japan
[8] Hamanomachi Hosp, Dept Med Oncol, Fukuoka, Japan
[9] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 812, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
757
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Change in systemic inflammation markers and CEA levels as predictive marker for chemotherapy response and prognosis in metastatic colorectal cancer
    Kim, In-Ho
    Lee, In Hee
    Lee, Ji Eun
    Oh, Seong Taek
    Kim, Jun Ki
    Lee, Myung Ah
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Predictive value of ERCC1 and KRAS in colorectal cancer patients with FOLFOX chemotherapy.
    Lee, In Kyu
    Choi, Sung-Bong
    Cheung, DaeYoung
    Kim, Jin Il
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [23] Therapy monitoring with FDG PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss, A
    Strauss, L
    Rudi, J
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 22P - 23P
  • [24] Carcinoembryonic antigen (CEA) surge in patients with metastatic colorectal cancer receiving systemic chemotherapy.
    Sunga, AY
    Ailawadhi, S
    Yang, GY
    Rajput, A
    Smith, JL
    Fakih, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 274S - 274S
  • [25] Reoperation for metastatic testis cancer after chemotherapy.
    Christmas, TJ
    Smith, GL
    Kooner, RS
    JOURNAL OF UROLOGY, 1998, 159 (05): : 49 - 49
  • [26] Response to chemotherapy and prognosis in metastatic colorectal cancer with deficient mismatch repair
    Alex, A.
    Siqueira, S.
    Coudry, R.
    Santos, J.
    Alves, M.
    Hoff, P.
    Riechelmann, R.
    ANNALS OF ONCOLOGY, 2016, 27 : 102 - 102
  • [27] Morphologic and genomic characterization of circulating tumor cells in patients with metastatic colorectal cancer treated with combinational treatment of andecaliximab, bevacizumab and chemotherapy.
    Shishido, Stephanie
    Kuhn, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] BRCAness and prognosis of triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
    Akashi-Tanaka, Sadako
    Tanino, Yuichi
    Yamamoto, Yutaka
    Nishimiya, Hiroshi
    Yamamoto-ibusuki, Mutsuko
    Iwase, Hirotaka
    Nakamura, Seigo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer
    Estevez-Garcia, Purificacion
    Rivera, Fernando
    Molina-Pinelo, Sonia
    Benavent, Marta
    Gomez, Javier
    Luisa Limon, Maria
    Dolores Pastor, Maria
    Martinez-Perez, Julia
    Paz-Ares, Luis
    Carnero, Amancio
    Garcia-Carbonero, Rocio
    ONCOTARGET, 2015, 6 (08) : 6151 - 6159
  • [30] Tissue gene expression analysis as a tool for optimising colorectal cancer chemotherapy.
    Ford, H
    Farrugia, D
    Cunningham, D
    Aherne, W
    Hill, M
    Danenberg, P
    Danenberg, K
    Jackman, A
    ANNALS OF ONCOLOGY, 2000, 11 : 60 - 60
12345